LEADER 00000cam a2200649Ia 4500
001 ocn761928167
003 OCoLC
005 20160527041005.2
006 m o d
007 cr cn|||||||||
008 111122s2012 enka ob 001 0 eng d
016 7 015880196|2Uk
020 9781849733502|q(electronic book)
020 1849733503|q(electronic book)
020 |z9781849731584
020 |z1849731586
035 (OCoLC)761928167
037 T3520|bRoyal Society of Chemistry|nhttp://www.rsc.org/spr
040 UKRSC|beng|epn|cUKRSC|dUKMGB|dITD|dOCLCQ|dYDXCP|dN$T|dMYG
|dOCLCF|dOCLCO|dOCLCQ|dOCLCO
049 RIDW
050 4 RS403|b.P43 2012eb
072 7 MED|x023000|2bisacsh
072 7 MED|x058170|2bisacsh
072 7 MED|x071000|2bisacsh
072 7 MED|x072000|2bisacsh
082 04 615.1/9|223
090 RS403|b.P43 2012eb
245 00 Pharmaceutical salts and co-crystals /|cedited by Johan
Wouters, Luc Quéré.
264 1 [Cambridge] :|bRoyal Society of Chemistry,|c2012.
300 1 online resource (xiv, 391 pages) :|billustrations (some
color).
336 text|btxt|2rdacontent
337 computer|bc|2rdamedia
338 online resource|bcr|2rdacarrier
340 |gpolychrome|2rdacc
347 text file|2rdaft
490 1 RSC drug discovery series,|x2041-3203 ;|vno. 16
504 Includes bibliographical references and index.
520 Multi-component crystalline materials (salts and co-
crystals) have received renewed interest due to their
importance in the pharmaceutical industry, and
pharmaceutical co-crystals and salts represent an emerging
class of pharmaceutical materials offering the prospect of
optimized physical properties, giving new, stable and
patentable solid forms. These multi-component crystalline
forms influence relevant physico-chemical parameters such
as solubility, dissolution rate, chemical stability,
melting point, and hygroscopicity, which can result in
solids with properties superior to those of the free drug.
This book covers the hot topic of pharmaceutical salts and
co-crystals focusing on the following essential aspects an
overview of fundamental aspects on salts and co-crystals,
racemic resolution via diastereomer separation,
optimization of relevant physico-chemical parameters and
strengthening of intellectual property. Combining both
reports of the latest research and comprehensive overviews
of basic principles, with contributions from selected
experts in both academia and industry, this unique book is
an essential reference, ideal for pharmaceutical
development scientists and graduate students in
pharmaceutical science.
588 0 Print version record.
590 eBooks on EBSCOhost|bEBSCO eBook Subscription Academic
Collection - North America
650 0 Pharmaceutical chemistry.|0https://id.loc.gov/authorities/
subjects/sh85023026
650 0 Crystals|xTherapeutic use.|0https://id.loc.gov/authorities
/subjects/sh2009122629
650 7 Pharmaceutical chemistry.|2fast|0https://id.worldcat.org/
fast/1060115
650 7 Crystals|xTherapeutic use.|2fast|0https://id.worldcat.org/
fast/884696
655 4 Electronic books.
700 1 Wouters, Johan.|0https://id.loc.gov/authorities/names/
nb2012000356
700 1 Quéré, Luc.|0https://id.loc.gov/authorities/names/
nb2012000357
710 2 Royal Society of Chemistry (Great Britain)|0https://
id.loc.gov/authorities/names/n81122723
776 08 |iPrint version:|tPharmaceutical salts and co-crystals.
|dCambridge, UK : RSC Pub., ©2012|w(OCoLC)781366392
830 0 RSC drug discovery series ;|0https://id.loc.gov/
authorities/names/no2010092643|v16.
856 40 |uhttps://rider.idm.oclc.org/login?url=http://
search.ebscohost.com/login.aspx?direct=true&scope=site&
db=nlebk&AN=519363|zOnline eBook. Access restricted to
current Rider University students, faculty, and staff.
856 42 |3Instructions for reading/downloading this eBook|uhttp://
guides.rider.edu/ebooks/ebsco
901 MARCIVE 20231220
948 |d20160616|cEBSCO|tebscoebooksacademic|lridw
994 92|bRID
